Literature DB >> 7723550

Prognostic classification of breast ductal carcinoma-in-situ.

M J Silverstein1, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon.   

Abstract

We present a new prognostic classification designated the Van Nuys classification for ductal carcinoma-in-situ (DCIS). The classification combines high nuclear grade and comedo-type necrosis to predict clinical recurrence. Three groups of DCIS patients were defined by the presence or absence of high nuclear grade and comedo-type necrosis: 1--non-high-grade DCIS without comedo-type necrosis, 2--non-high-grade DCIS with comedo-type necrosis, 3--high-grade DCIS with or without comedo-type necrosis. There were 31 local recurrences in 238 patients after breast-conservation surgery 3.8% (3/80) in group 1, 11.1% (10/90) in group 2, and 26.5% (18/68) in group 3. The 8-year actuarial disease-free survivals were 93%, 84%, and 61%, respectively (all p < or = 0.05). The Van Nuys classification defines three distinct and easily recognisable groups, each of which has a different likelihood of local recurrence if treated with breast conservation.

Entities:  

Mesh:

Year:  1995        PMID: 7723550     DOI: 10.1016/s0140-6736(95)90982-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  107 in total

Review 1.  The basic pathology of human breast cancer.

Authors:  E Mallon; P Osin; N Nasiri; I Blain; B Howard; B Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

2.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.

Authors:  A G Douglas-Jones; J M Morgan; M A Appleton; R L Attanoos; A Caslin; C S Champ; M Cotter; N S Dallimore; A Dawson; R W Fortt; A P Griffiths; M Hughes; P A Kitching; C O'Brien; A M Rashid; D Stock; A Verghese; D W Williams; N W Williams; S Williams
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

4.  Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.

Authors:  A G Douglas-Jones; J Logan; J M Morgan; R Johnson; R Williams
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

5.  The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.

Authors:  L Hayward; R S Oeppen; A V Grima; G T Royle; C M Rubin; R I Cutress
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

Review 6.  Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.

Authors:  Melvin J Silverstein; Michael D Lagios
Journal:  J Natl Cancer Inst Monogr       Date:  2010

7.  An adequate margin of excision in ductal carcinoma in situ.

Authors:  Malcolm R Kell; Monica Morrow
Journal:  BMJ       Date:  2005-10-08

8.  Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

Authors:  Mona L Gauthier; Hal K Berman; Caroline Miller; Krystyna Kozakeiwicz; Karen Chew; Dan Moore; Joseph Rabban; Yunn Yi Chen; Karla Kerlikowske; Thea D Tlsty
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

9.  Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Authors:  Kathleen Lambein; Mieke Van Bockstal; Lies Vandemaele; Rudy Van den Broecke; Veronique Cocquyt; Sofie Geenen; Hannelore Denys; Louis Libbrecht
Journal:  Virchows Arch       Date:  2017-05-31       Impact factor: 4.064

10.  Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.

Authors:  Jin You Kim; Jin Joo Kim; Ji Won Lee; Nam Kyung Lee; Geewon Lee; Taewoo Kang; Heesung Park; Yo Han Son; Robert Grimm
Journal:  Eur Radiol       Date:  2018-08-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.